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Background: Many medical situations necessitate a stressful period of waiting for potentially threatening test
results. The medical waiting period is often associated with negative anticipatory anxiety and rumination about the
outcome of treatment. Few evidence-based self-help coping interventions are available to assist individuals manage
these periods. Theory and research suggest that positive reappraisal coping strategies may be particularly useful for
this type of unpredictable and uncontrollable stressful context. The objective of this study is to investigate the
effects of a Positive Reappraisal Coping Intervention (PRCI) on psychological well-being of women waiting for the
outcome of their fertility treatment cycle.
Methods/Design: In a three-armed randomized controlled trial, the effectiveness of the PRCI will be tested.
Consecutive patients undergoing in vitro fertilisation in a Dutch university hospital and meeting selection criteria
will be invited to participate. Those who agree will be randomized to one of three experimental groups (N=372).
The PRCI Intervention group will receive the intervention that comprises an explanatory leaflet and the 10
statements designed to promote positive reappraisal coping, to be read at least once in the morning, once in the
evening. To capture the general impact of PRCI on psychological wellbeing patients will complete questionnaires
before the waiting period (pre-intervention), on day ten of the 14-day waiting period (intervention) and six weeks
after the start of the waiting period (post-intervention). To capture the specific effects of the PRCI during the
waiting period, patients will also be asked to monitor daily their emotions and reactions during the 14-day waiting
period. The primary outcome is general anxiety, measured by the Hospital Anxiety and Depression Scale. Secondary
outcomes are positive and negative emotions during the waiting period, depression, quality of life, coping and
treatment outcome. During recruitment for the RCT it was decided to add a fourth non-randomized group, a PRCI
Control group that received the PRCI and completed the questionnaires but did not complete daily monitoring.
Discussion: Positive reappraisal is one of the few ways of coping that has been shown to be associated with
increased wellbeing during unpredictable and uncontrollable situations like medical waiting periods. A simple
evidence based self-help intervention could facilitate coping during this common medical situation. This RCT study
will evaluate the value of a self-help coping intervention designed for medical waiting periods in women
undergoing fertility treatment.
Trial registration: The study is registered at the Clinical Tials.gov (NCT01701011).
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The diagnosis and treatment of various medical conditions
requires patients to wait for results that are potentially
threatening to their well-being (e.g., breast biopsy results,
pregnancy test results after fertility treatment, genetic
screening outcomes) [1]. The outcomes of these tests
are often unpredictable and often cause high levels of
anticipatory anxiety and uncertainty [2] that are difficult
to cope with. As the outcome of the medical tests or
procedures for which patients are waiting cannot be
changed or controlled, there is little point for the patient
in trying to alter the situation. Instead, coping efforts
should be directed at regulating the negative anticipatory
emotions associated with waiting (e.g., feeling nervous,
tense, worried, anxious) [3]. Despite the pervasiveness
of medical waiting periods, few studies have investigated
coping interventions to manage this stressful medical
context [4].
Meaning-based coping strategies have been observed to
be effective in contexts that involve a sustained period of
unpredictability and uncertainty. Tedlie Moskowitz et al.
[5] and Folkman and Moskowitz [6] observed that even in
very stressful and uncertain situation such as caring for a
terminally ill partner participants reported experiencing
positive feelings. One type of coping strategy associated
with these positive psychological states was positive
reappraisal coping, which helped the person to redefine
the situation in a more positive way, allowing them to de-
rive some benefit from the negative experience. Folkman
and Lazarus [3] proposed that these positive emotions had
an important role in motivating people to continue in
their efforts to cope in these ongoing stressful situations.
Fertility treatment is an example of a medical context
that requires patients to wait for several weeks for the
outcome of their treatment. The use of Assisted Repro-
ductive Techniques (ART) (e.g., In Vitro Fertilization
(IVF) and IntraCytoplasmic Sperm Injection (ICSI)) con-
tinues to increase and worldwide the total number of
babies born through IVF is now exceeds 5 million [7].
A cycle of in vitro fertilisation typically requires nine
to 12 days of self-injection with potent fertility drugs to
stimulate the production of oocytes (eggs), retrieval of
oocytes via trans-vaginal ultrasonography, fertilisation of
oocytes in the laboratory with partner or donor sperm,
and transfer of the resulting embryo to the uterus. Couples
then wait two weeks to find out whether implantation
and a pregnancy have occurred. Women often report that
IVF/ICSI is an emotional and physical burden that can
cause anxiety and stress [8,9]. The aspects most frequently
reported as stressful are the fourteen-day waiting period
between embryo transfer and the pregnancy test, and
being informed that the treatment was unsuccessful
[8-12]. Symptoms of anxiety and depression have been
shown to increase during the waiting period after ET[1,2,10,11]. The lack of control the patient has to influence
outcome during this period has also been shown to
contribute to the increase in distress [2].
Despite the emotional stress reported during fertility
treatment, many women do not seek professional support
[13,14]. The stated reasons for this are often practical,
such as the costs of counselling, distance to the appoint-
ment or being unsure how to arrange an appointment
[13]. Nevertheless, women still worry about the impact
of stress on the outcome of treatment and available
meta-analyses are inconclusive on such effects [15,16].
A meta-analysis of 31 prospective studies found a small
but significant association between stress, distress and
reduced pregnancy chances [15]. Another meta-analysis
of 14 prospective studies found no significant effect of
emotional distress on the chance of becoming pregnant
[16]. Several psychosocial interventions designed to support
women with infertility have been described [17,18].
However, these are mostly aimed at providing general
support throughout the entire fertility treatment and not
at a specific point in the treatment, such as the waiting
period. The impact of psychosocial interventions on
anxiety, depression, coping and treatment outcome is
inconsistent across reviews. One review of 25 studies
concluded that psychosocial interventions reduced nega-
tive affect such as anxiety and infertility-specific distress
but had no effect on pregnancy rates [17]. A subsequent
meta-analysis of 22 studies concluded that psychotherapy
was effective in reducing anxiety delivered in individual
and group format [19]. The pregnancy rate with assisted
reproductive techniques (ART) was similar in individual
and group therapy however there was a difference in
pregnancy rates between psychotherapy (45%) and the
control group (14%) [19]. A final meta-analysis of 21
controlled studies showed that psychosocial interventions
did not impact any form of psychological distress but
the meta-analysis for pregnancy rate was significant with
sub-group analysis showing increased pregnancy rate
but only in patients undergoing non-ART treatments
[18]. Inconsistent results could be due to interventions
being too general. Indeed, Boivin [17] found that interven-
tions with a strong educational and skills component
that focused on specific targets (e.g., coping training,
sex during fertile period) were more effective than those
focused primarily on emotional expression and support.
The Positive Reappraisal Coping Intervention (PRCI)
was designed to address unmet coping needs during med-
ical waiting periods such as waiting for fertility treatment
results. During the stressful waiting period after ET,
women do not normally attend a clinic for tests or pro-
cedures and therefore lose the opportunities they had to
receive informal support from the medical staff, clinic or
other patients undergoing treatment at the same time [1].
Individual counselling of women during the waiting period
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investment and costs [13]. The PRCI is self-administered
and comprises an explanatory leaflet describing this
method of coping and ten statements designed to promote
positive reappraisal coping. PRCI was conceptualised
from the cognitive model of stress and coping [20,21] and
developed according to the Medical Research Council
framework for developing complex interventions [1].
Lancastle and Boivin [1] investigated the acceptability
and feasibility of the intervention in an RCT of 55
women who used PRCI during the waiting period of an
IVF/ICSI cycle versus a control group reading ten control
positive statements. Results showed that the PRCI group
rated the intervention as more helpful and suitable for the
IVF/ICSI situation, more able to help women feel positive
as well as better in sustaining positive reappraisal coping
strategies during the waiting period. A feasibility study
in the Netherlands showed that it is possible to recruit
the amount of women necessary for the RCT in two years.
Furthermore, the majority of the 27 women included in
the study found the PRCI was suitable and feasible.
(unpublished data, Ockhuijsen). These results suggest
that PRCI could be useful for medical waiting periods.
However, its effectiveness on general or treatment-specific
anxiety has not yet been systematically evaluated in a
randomized controlled trial.
Methods/Design
The PRCI will be evaluated in a three-arm Randomized
Controlled Trial (RCT). Participants will be randomized
to an intervention, monitoring control group or routine
care. To capture the general impact of the PRCI all three
groups will complete questionnaires at three time points:
just before the waiting period (Time 1: pre-intervention),
on Day 10 of the 14-day waiting period (Time 2: inter-
vention) and 6 weeks after the start of the waiting period
(Time 3: post-intervention). Table 1. Mobile phone text
reminders will be sent to patients about completing the
Time 1 and Time 3 questionnaires (if necessary) and allTable 1 Measurement timetable according to group
Measurements T1 hCG to Embryo transfer
BIF 1,2,3,4
HADS 1,2,3,4
FertiQol 1,2,3,4
WCQ 1,2,3,4
DRK one day 1,2,3,4
IEF ————
DRK daily ————
Medical chart review ————
Note. Numbers refer to group: 1 = PRCI Intervention, 2 = Monitoring Control, 3 = Rou
Information Form, HADS = Hamilton Anxiety and Depression Scale, FertiQol = The F
Record Keeping, IEF = Intervention evaluation form.patients will receive a reminder just prior to the Time 2
assessment on the ninth day of the waiting period.
To capture the specific impacts of PRCI on the waiting
period the intervention group will rate daily their emo-
tions and reactions during the 14-day waiting period. Daily
monitoring has previously been shown to be an efficient
and sensitive way of evaluating emotional reactions during
fertility treatment [2,9] and to be sensitive to intervention
effects during ART [22]. One potential drawback of this
method of assessment is that it may impact on the
reporting of emotions itself. For example, habituation
or sensitisation to monitoring per se may decrease or
increase reporting of anxiety compared to groups that
do not monitor [23]. Due to this potential reactivity the
monitoring control group will also monitor emotions and
reactions daily during the waiting period. The routine care
control group will not receive the intervention or monitor
reactions.
During recruitment for the RCT it was decided to add
a fourth non-randomized group. The decision to add
this group was based on preliminary results of on-going
qualitative research with the PRCI and daily monitoring
among women who had experienced miscarriages (unpub-
lished data, Ockhuijsen). The women in the miscarriage
study reported that the daily monitoring had an effect
on their emotions in that it helped them take account
of the impact of miscarriages on their emotional lives.
If daily monitoring was itself an intervention then it
could attenuate, heightened or obscure effects of the
PRCI intervention in unknown ways. Therefore it was
decided to add a PRCI Control group that received the
PRCI and completed the questionnaires but did not
complete daily monitoring.
Participants/recruitment
The RCT will be conducted over a two-year period in a
fertility clinic at a University hospital in the Netherlands.
See Figure 1 for the flow chart of the study. The opt-in
method will be used to recruit participants. In thisT2 Day 10 waiting period T3 Six weeks after ET
———— ————
1,2,3,4 1,2,3,4
1,2,3,4 (Treatment only) 1,2,3,4 (non-pregnant group only)
1,2,3,4 1,2,3,4
3,4 ————
1,4 ————
1,2 ————
———— 1,2,3,4
tine Care and 4 = PRCI Control (non-randomized). BIF = Background
ertility Quality of Life, WCQ = Ways of Coping Questionnaire, DRK = Daily
T1 Baseline measures
Group 2
T2 DRK & 
Quest
T3 Post treatment measures
Pregnant group/Non pregnant group
Randomization
Group 3
T2 Quest
Group 1
T2 PRCI & 
DRK & Quest
Group 4
T2 PRCI & 
Quest
Opt in method
R
ecruitm
ent
Stim
ulation
W
aiting period
Figure 1 Flow chart study protocol.
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themselves contact the team to take part. The inclusion
criteria will be all women undergoing a stimulated or
cryopreserved IVF/ISCI treatment. The exclusion criteria
will be women not speaking the Dutch language. All
women meeting these criteria and starting a treatment will
be sent a letter with general information about the study.
Doctors and nurses working in the fertility clinic will
remind women of the letter and the study. Patients
who are interested in the study will return a reply form
or e-mail indicating their interest and a researcher will
contact them to give more information about the study
and answer any questions. Those who decide to partici-
pate will be sent a written information sheet and a consent
form to return in a pre-addressed stamped envelope.
During their first visit to the hospital, more information
will be given about the logistics of the study, as needed,
but all patients will be given the same information
according to a written protocol.
The fourth group will be recruited as for the RCT.
The fourth group will receive the same information as
the participants from the RCT. Although this group
will not be randomized, participants will be told that
randomization will take place. Participants will be fully
debriefed about the need for this deception at the end
of the study.The Ethical committee of the University of Utrecht
provided ethical review and approval for this study,
including the addition of the fourth non-randomized
group (protocol number 10-174/K).
Sample size
The sample size calculation for the three-arm RCT is
based on the following parameters. To test the difference
on anxiety between three groups using a mixed factorial
ANOVA, power of 95%, α = 0.05 and a medium effect
size a total of 297 subjects was required (99 patients
per group) [24,25]. However, taking into account a 20%
attrition rate at least 124 women will be recruited in
each group. Effect size and attrition were derived from
Lancastle and Boivin [1]. The addition of the fourth group
only slightly modified sample size and 110 participants
were recruited to the fourth group.
Randomization
Stratified randomization of the 372 women into one of
the three groups will be performed by using a computer-
generated table of random numbers. The type of treat-
ment (stimulated or cryopreserved IVF/ICSI) will stratify
the population because emotions and expectations relative
to a stimulated IVF/ICSI may differ from a cryo-preserved
treatment [26,27]. Randomization will take place after
Figure 2 PRCI intervention. © 2008 by Cardiff University. All rights
reserved. No part of this document may be reproduced or
transmitted in any form or by any means, electronic, mechanical,
photocopying, recording, or otherwise, without prior written
permission of authors.
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follicle aspiration and embryo transfer. An independent
research nurse will be responsible for the randomization.
Double blinding will take place for participants and clinic
staff. Participants will not be told what intervention is
being evaluated. The researcher will have no contact
with participants after randomization. All women will
receive written information about group assignment on
the day of the embryo transfer. They will receive instruc-
tions for the waiting period in an opaque sealed envelope
after the embryo transfer. The clinical staff that performs
the embryo transfer will be blinded for the content of
the envelope. After the embryo transfer, there will be no
further contact between the clinical staff, other patients,
or the researcher during the 14-day waiting period.
Intervention and control groups
Patients will be randomly assigned to one of the three
groups: PRCI Intervention, Routine Care Control and
Monitoring Control. In addition data will be collected
for the PRCI Control.
The PRCI Intervention and PRCI Control groups will
receive the PRCI. The PRCI is a small card that contains
ten positive reappraisal statements and a leaflet with a
detailed explanation about this coping approach. See
Figure 2 for the PRCI card. Women will be instructed to
read the PRCI at least twice a day, once in the morning
and once in the evening as well as at any time they feel
the need, and to think about how each statement applies
to them personally. The other groups will not receive the
PRCI. The Monitoring Control group will complete daily
monitoring and questionnaires, whereas the Routine Care
Control and PRCI Control groups will only complete
questionnaires.
Objective
The aim of this study is to investigate the effect of the
PRCI on psychological well-being of women waiting for
the results of an IVF/ICST treatment. The primary outcome
is level of general anxiety measured before the waiting
period (pre-intervention), on day ten of the 14-day waiting
period (intervention) and six weeks after the start of the
waiting period (post-intervention). Secondary outcomes
are positive and negative treatment emotions during the
waiting period, depression, coping style, quality of life and
treatment outcome.
Hypotheses
The PRCI increases the use of positive reappraisal coping
strategies and reduces symptoms of general anxiety and
depression, improves quality of life across assessment
(pre intervention, intervention and post intervention)
as well as increases positive and decreases negativeemotions during the fourteen days of the waiting period
in patients undergoing an IVF/ICSI treatment.
Study measures
Data will be obtained with self-reported questionnaires,
daily monitoring and from the treatment medical records.
Table 1 shows the assessment timetable. Questionnaires
will be completed prior to, during and after the interven-
tion whereas monitoring will be daily during the two-week
waiting period. The following self-report measures will
be used:
The Background Information Form (BIF) is a 16-item
questionnaire to measure demographic (e.g. age, educa-
tional status), medical (e.g. previous illness) and gynae-
cological (e.g. infertility diagnosis, previous infertility
treatment) characteristics as well as treatment expecta-
tions (e.g. chances of conceiving, perceived control over
the outcome).
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will be used to measure general anxiety and depression.
The HADS consists of 14 items (7 items for each
subscale) that are rated on a 4-point Likert scale. The
total score is the sum of the 14 items, and for each
subscale the score is the sum of the respective seven
items (ranging from 0–21). Scores on each scale can be
interpreted in ranges: normal (0–7), mild (8–10), moderate
(11–14) and severe (15–21). The Dutch version of the
HADS has been shown to be a valid and reliable instru-
ment [28].
The Fertility Quality of Life (FertiQoL) scale will be used
to measure the impact of infertility and its treatment.
FertiQoL consist of 36 items that assess core (24 items)
and treatment related quality of life (10 items) and overall
life and physical health (2 items). Items are rated on a
5-point response scale. Cronbach reliability coefficients
for the Core and Treatment FertiQoL were 0.92 and
0.81, respectively [29]. The convergent validity of the
Dutch version of the FertiQoL has been investigated
and shows similar reliability [30]. Items are summed and
scaled, with a range of 0 to 100. Higher scores indicate
better quality of life.
The Ways of Coping Questionnaire (WCQ) will be used
to measure use of coping strategies. The WCQ is based
on the cognitive stress and coping model of Lazarus
and Folkman [31,32]. The instrument is designed to
measure situation-specific coping. The 41 items of the
Dutch version are rated on a 4-point response scale that,
when summed, yields 6 subscales. Taking responsibility
(6 items), problem solving (8 items), social support (6
items), wishful thinking (8 items), avoidance (7 items),
positive reappraisal (6 items). The Cronbach alpha coeffi-
cients reported for the six subscales ranges from 0.65
to 0.80. To measure the concurrent validity the WCQ
has been compared with the seven scales of the Utrecht
Coping List with good correspondence between these [33].
The Intervention evaluation form (IEF) is a 24-item
questionnaire developed to assess intervention feasibility,
acceptability and effects, which was used to assess PRCI
in previous research [1]. It measures the following aspects
of the intervention: practicality (6 items), acceptability
(4 items), endorsement (4 items), perceived psychological
effects (8 items) and perceived duration of intervention
effects (2 Items).
The Daily Record Keeping (DRK) sheet will be used
daily to rate reactions to the 14-day waiting period (PRCI
Intervention and Monitoring Control groups only). The
DRK comprises 46 possible reactions to the IVF waiting
period, including 20 emotions, optimism and pessimism
about pregnancy, 12 physical symptoms, five appraisals,
and seven coping strategies. The emotional subscale is
based on the theory of Lazarus and Folkman [20] and
contains affective reactions that are averaged to produceanxiety (i.e., tense, nervous, worried), depression (i.e., anger,
frustrated, sad) and positive affect (i.e., happy, content,
fulfilled). The five coping strategies are measured with
Stone and Neale’s [34] daily coping measure namely
strategies of distraction, positive redefinition, problem-
focused, seeking emotional support and acceptance. The
twelve physical symptoms list two common side effects
of medication (i.e., abdominal discomfort, spotting), two
symptoms related to treatment success/failure (e.g., breast
tenderness, menstrual cramps) and the remaining eight
symptoms originate from the physical stress reactions
(e.g., racing heart, muscle tension) of the Pennebaker
Inventory of Limbic Languidness (PILL) [1]. Subscale
scores were created (where relevant) by averaging across
subscale items and higher scores indicate more of the
attribute (e.g., more tension, breast tenderness, distraction).
Participants will be instructed to complete the DRK at
the end of the day, and for the PRCI intervention group
at least one hour after reading the PRCI card to limit the
chance of DRK ratings being artificially and transiently
influenced by completing the DRK.
The DRK has been shown to be acceptable for moni-
toring during protracted periods of treatment with 15%
attrition during 75 days of monitoring and 9% over a
period of 30 days [9]. The reported Cronbach alpha
ranges from 0.70 – 0.82 for subscales [2]. The DRK was
translated and used in a Dutch study [22] that showed
good correspondence between the original and Dutch
version, and acceptable convergent and discriminant val-
idity with other measures of anxiety and depression. The
DRK was also tested in a feasibility study in a population
from the recruitment clinic in the Netherlands showing
acceptability and feasibility (unpublished data, Ockhuijsen).
A medical chart review at the end of treatment will be
used to obtain treatment data and will include the total
number of past IVF/ICSI stimulated and cryopreserved
cycles, past intrauterine insemination cycles, previous
conceptions/births, infertility diagnosis, smoking status,
alcohol use, and body mass index. Data about the current
treatment will include: type of treatment and protocol,
date of first and subsequent treatment attempt, treatment
cancellation (yes/no) and reason for cancellation, number
of oocytes retrieved, total number of embryos created,
transferred and cryopreserved, treatment outcome (posi-
tive pregnancy test, clinical pregnancy, live birth), physician
recommendation for next cycle and patient compliance
with physician recommendation”.
Statistical analysis
IBM SPSS Statistics will be used to perform the statistical
analysis. Equivalence of baseline measures between groups
will be examined by one-way analyses of variance (ANOVA)
for normally distributed variables on interval or ratio
level, chi-square for normally distributed variables on
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distributed variables on ordinal level. If study variables
are not normally distributed then data will be transformed
to normalise (e.g., square root, log, etc. as is required). If
the groups are not comparable on demographics, medical
history or gynaecological variables, those variables will
be employed as covariates in subsequent analyses. To
examine the differences between groups over time a
repeated measure mixed factorial ANOVA design will be
used for variables on interval or ratio level. To compare
the fourth group with the three separate groups also an
ANOVA design will be used. Intention to treat and
multi-level modelling will be used to analyse the data
to take account of attrition.
Discussion
Waiting for a potentially threatening medical test result
in a period where there is no control in the outcome is
very stressful and can bring about feelings of tension,
nervousness and worry. The Positive Reappraisal Coping
Intervention (PRCI) investigated in this RCT was specif-
ically designed to help people cope with these medical
waiting periods. Positive reappraisal coping is a set of
strategies in which the significance of the event is
reinterpreted in a more positive way [6]. In the present
study, we will evaluate the effectiveness of the PRCI on
psychological wellbeing of woman waiting for the results
of an IVF/ICSI treatment cycle. Although the effectiveness
of the PRCI has not yet been investigated, the coping
literature shows that positive reappraisal strategies are
one of the few ways of coping that are associated with
increased positive affect and sustained ability to cope in
unpredictable and uncontrollable stressor situations [6].
The results of this study could therefore be important
because there is a lack of inexpensive self-help evidence
based coping-interventions that could be used during
the common medical waiting period.
This study has several strengths. This RCT was devel-
oped based on the results of several previous studies.
The framework for developing complex interventions
was used to design the PRCI and provide evidence of
feasibility and acceptability in the studied population
[1,35]. The MRC framework guides development to be
theory based to create active components that can be
delivered effectively during the RCT. Also the develop-
ment and validation of the assessment tools was based on
previous research showing good psychometric properties
in Dutch translations for the key measures [1,9]. We chose
a three-armed RCT to ensure balance between the deter-
mination of the general impacts of PRCI measured by
questionnaires and its more specific impacts on the
waiting period measured by monitoring. The Monitoring
Control group of women who only monitor will allow us
to disentangle effects due to PRCI and those due tomonitoring per se on emotions and reactions during
the waiting period. The RCT procedures match those
of high quality trials with randomization and allocation
concealment, blinding of patients and clinical staff [36].
The decision to add the PRCI Control after the RCT has
the disadvantage that this group will not be randomized.
However, the group will allow us to estimate PRCI effects
independent of daily monitoring, in case monitoring has
an unexpected intervention effect that interacts with PRCI
effects. Our RCT procedures use written protocols and
blinding which should minimise the chance of systematic
bias even in this non-randomized group with respect to
attributes that may affect the dependent variables. The
expected sample size will provide adequate power for
detection of effects, determined from previous studies
using the PRCI tool.
A limitation of this study is the method used for
recruiting the participants. The opt-in method was
employed to recruit on the advice of the Ethics Committee.
In this method participants are sent an invitation to the
trial and themselves contact the team to take part, which
differs from the more conventional opt-out approach
where all patients are contacted about the trial unless they
have contacted the team to indicate that they do not wish
to be approached. Although the opt-out method improves
recruitment, the ethical committee often does not approve
this method because repeated contact is too burdensome
for participants [37,38]. In the study of Junghans at al.
[37] there was a difference in risk factors between the
two methods. Patients in the opt-in arm had fewer risk
factors (44%) compared to patients in the opt-out arm
(60%) (P = 0.053).
Another limitation could be the participation of only
one hospital. We choose to recruit in only one hospital
because this university hospital attracts patients from all
over the country. However, as there is collaboration with
other clinics nationwide inferences about the general-
izability of findings can be determined via comparison
of patient characteristics collected as part of wider
collaborations.
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